Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
ID: 350787Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350787

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting applications for research on the ethical, legal, and social implications (ELSI) of human genetics and genomics. This initiative aims to support multidisciplinary research that engages diverse stakeholders and addresses systemic issues related to genomic research and healthcare equity, with a specific requirement for a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. The research is intended to improve understanding of genetic research implications across various populations, focusing on public health issues such as cancer disparities and mental health. Applications will be accepted starting January 19, 2024, with a project period of up to five years, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-293-Full-Announcement.html
    PAR-23-293.html
    The Department of Health and Human Services, through the NIH, has released a Notice of Funding Opportunity (NOFO) inviting applications for research on the ethical, legal, and social implications (ELSI) of human genetic and genomic advancements. This initiative encourages multidisciplinary approaches involving diverse stakeholders, emphasizing the importance of community engagement. The funding opportunities target various NIH institutes, fostering inclusivity in research via the required Plan for Enhancing Diverse Perspectives (PEDP). Key dates include an opening date for application submissions on January 19, 2024, with a proposal project period extending to a maximum of five years. The application process entails strict adherence to NIH guidelines, including a comprehensive data management and sharing plan. The overarching goal is to support research that improves understanding of genetic research implications across diverse populations, addressing historical inequities and fostering ethical genomic practices. Topics of interest span various public health issues, including but not limited to cancer disparities, mental health implications, and genomic healthcare integration. This NOFO aims to harness scientific innovation by engaging diverse perspectives and addressing systemic issues related to genomic research and healthcare equity.
    Similar Opportunities
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)" aimed at enhancing workforce diversity in genomics research. This initiative seeks to support educational programs that provide research experiences and skills development for individuals from diverse and underrepresented backgrounds, particularly targeting undergraduate and post-baccalaureate trainees. The program emphasizes the importance of mentorship and innovative educational strategies to foster a diverse research community, ultimately driving advancements in biomedical sciences and improving health equity. Interested applicants can find more information and submit proposals through Grants.gov, with a funding ceiling of $325,000 and a submission deadline of January 27, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.
    Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the Ethical, Legal, and Social Implications (ELSI) Congress, supported by a cooperative agreement aimed at enhancing collaboration within the multidisciplinary ELSI research community. The initiative seeks to fund three biennial congresses that will facilitate research sharing, promote accessibility through hybrid formats, and encourage participation from underrepresented groups, particularly focusing on early-career scholars and trainees. With a budget of $350,000 allocated for the first congress scheduled for 2026, applications are due by November 19, 2024. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-028.html.